Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats
- 1 November 2000
- journal article
- Published by Elsevier BV in Pharmacology Biochemistry and Behavior
- Vol. 67 (3), 397-403
- https://doi.org/10.1016/s0091-3057(00)00306-3
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortexBiological Psychiatry, 1999
- α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive functionBiological Psychiatry, 1999
- Catecholamine modulation of prefrontal cortical cognitive functionTrends in Cognitive Sciences, 1998
- Noise Stress Impairs Prefrontal Cortical Cognitive Function in MonkeysArchives of General Psychiatry, 1998
- Positron Emission Tomography Measurement of Cerebral Metabolic Correlates of Yohimbine Administration in Combat-Related Posttraumatic Stress DisorderArchives of General Psychiatry, 1997
- The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive FunctionArchives of General Psychiatry, 1996
- Family-Environment Risk Factors for Attention-Deficit Hyperactivity DisorderArchives of General Psychiatry, 1995
- Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtypeNeuropharmacology, 1991
- The Role of Frontal Dysfunction in Attention Deficit Hyperactivity DisorderJournal of Child Neurology, 1991
- The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypesJournal of Neuroscience, 1988